GPT and hepatitis B virus infection: It is considered that the normalization of only ALT by DDB treatment does not indicate therapeutic efficacy, therefore DDB is not recommended for the routine treatment of chronic liver diseases(23), especially in the anti-hepatitis B therapy during which the ALT levels is only a monitoring marker of anti-viral efficacy.